Mechanobullous disorders

Published on 08/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 2 (1 votes)

This article have been viewed 3198 times

Chapter 6 Mechanobullous disorders

4. Describe the clinical findings in EB simplex.

In the common localized variety, the presentation is that of easy blistering noted on the hands and feet. These individuals may go undiagnosed until they are placed in a situation that generates increased pressure to these surfaces, such as marching in the military (Fig. 6-2). The generalized form is also usually present at birth, but, on rare occasions, it may not appear until 6 to 12 months of age in areas of trauma. The affected areas generally heal without scarring. In the simplex forms, generally the skin is the only thing affected; however, in the more severe forms of generalized simplex, they can have oral mucosa involvement and, on rare occasions, have esophageal strictures. The good news is that in some of the severe forms of generalized simplex EB the blistering tends to improve as the child ages. This is true for both the intraoral and cutaneous lesions.

5. Is the cause of EB simplex known?

Yes. In the vast majority of cases simplex EB is due to a mutation in either keratin 5 or 14 (Fig. 6-3). Keratins are structural proteins within keratinocytes that give the keratinocytes their shape and size, similar to the frame in a house. Keratins 5 and 14 are expressed in the basal layer of the epidermis, which is why the split is in the epidermis in EB simplex. There are rare forms of EB simplex that involve other structural proteins within the epidermis, such as plakophilin, desmoplakin, plectin, and integrins. Of interest is the simplex form of EB involving the protein plectin. Plectin is also important in skeletal muscle and individuals affected by the plectin form of EB simplex develop muscular dystrophy, usually after puberty.

Charlesworth A, Gagnous-Palacios L, Bonduelle M, et al: Identification of a lethal form of epidermolysis bullosa simplex associated with a homozygous mutation in plectin, J Invest Dermatol 121:1344–1348, 2003.

6. What are the clinical findings in junctional EB?

At birth, a few blisters may be present over areas of trauma, and it may be impossible to tell this type from EB simplex or the dystrophic type. However, infants may have oral erosions that are not found in EB simplex. Junctional EB includes localized variants that are not as involved and a severe generalized form (lethal) that typically results in death prior to the age of two (Fig. 6-4). As with EB simplex, blisters and erosions over areas of trauma are common. In contrast to those with EB simplex, children with the lethal form of JEB have prominent central facial erosions with hypergranulation tissue that is difficult to treat. They also have dental defects, nail dystrophy, and tracheal and bronchiolar involvement producing respiratory distress, which is often the cause of death. The other common cause of death in infants with the lethal JEB is sepsis.

8. What are the clinical findings in dystrophic EB?

In the recessive form of this condition, hemorrhagic blisters are typically present at birth. The blistered areas heal with scarring that can lead to the loss of functional digits in the hands (Fig. 6-5). Oral and esophageal involvement causes feeding problems with resultant esophageal stricture. The teeth are malformed, and multifactorial anemia is common. The dominant form of the disease is less severe and tends to be more localized. Atrophic scarring is still the rule over affected areas. A unique dominant dystrophic form exists (transient bullous dermolysis in the newborn) that is only transient. The blistering tendency decreases with age.

Christiano AM, Fine JD, Uitto J: Genetic basis of dominantly inherited transient bullous dermolysis of the newborn: a splice site mutation in the type VII collagen gene, J Invest Dermatol 109:811–814, 1997.

Das BB, Sahoo S: Dystrophic epidermolysis bullosa, J Perinatol 24:41–47, 2004.

11. Can a definitive diagnosis of the various EB types be made on clinical presentation?

No. In newborns and infants, it is virtually impossible to tell these disorders apart. Several techniques can aid in establishing the correct diagnosis. One such technique is immunomapping, which involves the use of antibodies directed against known proteins located at specific sites in the skin. The patient’s skin is subjected to minor trauma followed by a biopsy. The specimen is then “mapped” with the locating antibodies (Fig. 6-6). This technique locates the actual level of the blister formation in the skin specimen and determines the major category of mechanobullous disorder (i.e., epidermal, junctional, or dystrophic). The diagnosis can be further refined by using monoclonal antibodies that are specific for the missing or altered proteins. At many institutions, where electron microscopy (EM) is available, the tissue is also examined under EM, which can add additional information in making the diagnosis of EB (Fig. 6-7).

12. Are there any treatments for the mechanobullous disorders?

There are no specific treatments for this group of disorders. The current standard of care for these infants is strict wound care and infection control. Nonadherent dressings and padding are used to help blister heal and decrease trauma to the skin. Bathing can be quite painful for these children, especially for those that have the more severe forms of EB. Adding one pound of pool salt to a full tub of water has been found to help alleviate the pain with bathing.

In variants with oral manifestations, such as junctional EB and recessive dystrophic EB, meticulous oral hygiene with close dental follow-up is essential. Capping, crowns, and restorations can be helpful. Blenderized food is necessary early on for patients with recessive dystrophic EB to help minimize trauma to the esophagus and prevent esophageal webbing. Hand deformities in dystrophic EB can be surgically corrected, but the recurrence rate is high. There is extensive research in the area of gene therapy for the various forms of epidermolysis bullosa.

When dealing with a newborn with suspected EB it is best to contact one of the national organizations that deals with EB, such as the Dystrophic EB Research Association (www.DebRA.org), which can provide both clinical as well as family support. In addition, one can contact one of the five large multidisciplinary EB clinics in North America (Stanford University, Stanford, CA; Children’s Hospital, Aurora, CO; Cincinatti Children’s Hospital, OH; Hospital for Sick Children, Toronto, Canada; and Columbia University, New York).